Background: Moxifloxacin exerts excellent antibacterial activity against most putative periodontal pathogens and has been shown to kill bacteria in biofilm and host cells.
Methods: Patients with chronic periodontitis were randomly assigned to receive a single subgingival application of a 0.125%, 0.